[ad_1]
The world’s first green light to use the vaccine against COVID-19 from Pfizer me BioNTech comes from United Kingdom, which will be one of the First to vaccinate its population. Treatment approval came from Mhra, the UK drug regulatory agency. ButMom, the EU regulatory body that will discuss the same drug no later than December 29, coldly welcomed the decision of London, taken in record time: i legislators, reports Reutersin fact, they have warned against hasty approval of vaccines. The institution stated that its procedure is more appropriate since it is based on careers try out me control S than the emergency chosen by Britain. The announcement also sparked a “war” of tweets between the German ambassador in London and Government Minister Johnson.
Peter lieseThe MEP representing the CDU in Brussels recommended “to the EU member states not to repeat the British procedure.” “A few weeks of in-depth review by the EMA is better than a hasty authorization to get a vaccine on the market,” he said. According to European standards, the vaccine Pfizer must be authorized by the EMA, but the countries ofUnion may use an emergency procedure that allows them to deploy a vaccine for temporary use. Until the Brexi will not be final, that is, at the end of the year, the United Kingdom will be subject to European standards. As for Italy, the Minister of Health Roberto Speranza the Senate specified that “to date, two dates of Mom, who could comment on the vaccine on December 29 Pfizer-Biontech and January 12 about the vaccine Modern. These two companies in the first quarter of next year by contract should supply us 8,749 million doses respectively Pfizer-Biontech and 1,346,000 doses Modern. As I speak to you – added the minister – there are no other dates set by Ema ”.
The former director of EMA: “Fundamentally political decision” – By Guido Rasi, former executive director of the European Medicines Agency, the decision of London seems “substantially political” and “irrelevant to procedures Mom“It is an emergency authorization to extend the use to the general population of the lot currently available for clinical trials,” he explains. Rasi, who led the Authority on two occasions, the last from 2015 to mid-November, also experiencing the relocation of headquarters first-hand Mom gives London ad Amsterdam own cause Brexi. An approval, that of United Kingdom, which arrived “a few days before the probable authorization of the EMA – Rasi emphasizes – which includes all aspects of quality for mass distribution. Little additional risk “the one assumed Beyond the canal, “Reasonable – he comments – but of only political value“.” Certainly – said the former number one Ema this morning a Radio Capital – if you only evaluate partial data, as they are doing, you also get a minimal risk. I personally would have expected one robust review on all available data. “
Distribution of the vaccine in the UK – Pfizer said it will start shipping immediately supplies limited in the UK and is preparing for a release yet wider if you also receive authorization to use the vaccine from the Food and Drug Administration (FDA) of the United States, a decision that could come next week. Even the USA andEuropean Union In fact, they are looking at the Pfizer vaccine, along with a similar vaccine made by the competitor. Modern.
CEO of Pfizer Albert bourla called the UK’s decision “a Historic moment“. The UK has ordered doses of the Pfizer vaccine for 20 million people, but it is not yet clear how many will arrive before the end of the year. According to British media reports, the hospitals The country has been told to prepare for vaccines as soon as next week. the Health workers and guests of nursing homes will be the first to be vaccinated, followed by Old people. “We are focusing on moving with the same level of urgency to safely provide a high quality vaccine around the world, ”Bourla said in a statement. In addition to the challenges of distribution, Pfizer vaccine must be stored extremely low temperatures. For vaccination they are necessary two doses at a range of three weeks. The vaccines manufactured by the American company Pfizer and its German partner BioNTech were tried its Tens of thousands from the people. Although the study is not full, the first results suggest that the vaccine is 95% effective in the prevention of Covid-19 disease in stages of dear grave.
The Johnson administration maintains that Brexit has benefited from the swift action of UK regulators and did justice to London’s controversial decision to disassociate itself from the EMA podestà and the EU collective program for the supply of anti-Covid vaccines already in recent months: even before the end of the post-divorce transition phase scheduled for less than a month . A choice that has allowed London independently reserve more than 350 million doses of seven different candidate vaccines (40 million of which from Pfizer); and left more room for Mrha’s flexibility, empowered to start testing prototypes as experimentation progressed, and not starting from the end of testing as in the case of EMA. A difference that for the European agency would reflect a less appropriate method, but that for the British Minister of Health, Matt hancock, Mrha himself and the Kingdom’s scientific advisers, really guarantee “Exactly the same security checks“Guaranteed in EU countries. Only faster.
Meanwhile, Russian President Vladimir Putin has ordered mass vaccination to begin in Russia by the end of next week. The order came a few hours after British authorities approved the use of the Pfizer-BioNTech vaccine. “We organize the process so that large-scale vaccination begins at the end of next week,” Putin told Golikova. According to the Russian president, two million doses of the experimental Russian vaccine Sputnik V they have already been or will be produced in the coming days and this should allow doctors and teachers to receive the two necessary injections of the vaccine.
[ad_2]
